Sen. Sanders pushes NIH to rein in drug prices

(By Sydney Lupkin for NPR)

Can the National Institutes of Health bring down drug prices? It doesn’t approve new medicines or pay for them, but its role in drug research gives it surprising leverage. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org